15.01.2025 12:47 | PEEL, VAL | Holding(s) in Company | RNS |
15.01.2025 11:29 | VAL | Holding(s) in Company | RNS |
14.01.2025 07:00 | VAL | Holding(s) in Company | RNS |
09.01.2025 11:37 | VAL | Holding(s) in Company | RNS |
09.01.2025 11:14 | VAL | Holding(s) in Company | RNS |
08.01.2025 07:00 | VAL | Holding(s) in Company | RNS |
02.01.2025 11:45 | VAL | Holding(s) in Company | RNS |
31.12.2024 13:06 | VAL | Holding(s) in Company | RNS |
31.12.2024 10:58 | SAR, VAL, ROSE | AIM WINNERS & LOSERS: Strong 2024 for Quadrise and Rosebank | Alliance |
31.12.2024 10:58 | VAL | ValiRx extends TheoremRx exclusivity period to final May 31 deadline | Alliance |
31.12.2024 08:39 | VAL | Update on proposed sub-license of VAL201 | RNS |
30.12.2024 13:30 | VAL | Result of GM, Issue of Equity, Warrants and TVR | RNS |
20.12.2024 07:00 | VAL | ValiRx launches new interactive investor website | Reach |
22.11.2024 07:00 | VAL | Inaphaea award of HEIF Funding and PhD sponsorship | RNS |
20.11.2024 18:09 | VAL | IN BRIEF: ValiRx extends Ambrose Healthcare exclusivity agreement | Alliance |
20.11.2024 07:00 | VAL | Update on proposed sub-license of VAL401 | RNS |
19.11.2024 11:39 | VAL | ValiRX adds to streak of deals with cancer cell test materials win | Alliance |
19.11.2024 10:39 | WBI, VAL, LLAI | AIM WINNERS & LOSERS: Woodbois subscription raises over GBP1 million | Alliance |
18.11.2024 12:21 | VAL | IN BRIEF: ValiRx notes subsidiary's shipment of patient derived cells | Alliance |
30.10.2024 07:00 | VAL | Update on proposed sub-license of VAL201 | RNS |
18.10.2024 07:00 | VAL | Directorate Change | RNS |
14.10.2024 07:00 | VAL | Investor Webinar | RNS |
07.10.2024 07:00 | VAL | Inaphaea Co-Marketing Agreement | RNS |
27.09.2024 13:56 | ROQ, KDNC, VAL | EARNINGS: Kendrick Resources loss narrows; Emmerson CFO to depart | Alliance |
27.09.2024 07:00 | VAL | Half-year Report | RNS |
24.09.2024 07:00 | VAL | Inaphaea Co-Marketing Agreement | RNS |
18.09.2024 07:00 | VAL | Inaphaea Evaluation and Commercial Use Agreement | RNS |
16.09.2024 07:00 | VAL | Inaphaea Co-Marketing Agreement | RNS |
09.09.2024 22:03 | PANR, UKOG, CIZ | TRADING UPDATES: Light Science Technologies wins two new contracts | Alliance |
09.09.2024 07:00 | VAL | Inaphaea Evaluation and Commercial Use Agreement | RNS |
09.09.2024 07:00 | VAL | Investor Evening | RNS |
27.08.2024 07:00 | VAL | Inaphaea Evaluation and Commercial Use Agreement | RNS |
12.08.2024 12:01 | FLTR, IGG, SBRY | EXECUTIVE CHANGES: New chief executives at Cornish Metals and ValiRx | Alliance |
12.08.2024 07:00 | VAL | Directorate Change | RNS |
25.07.2024 07:00 | VAL | Directorate Changes | RNS |
03.07.2024 18:33 | AFRN, TUN, JSE | EXECUTIVE CHANGES: Jadestone Energy's CFO Bert-Jaap Dijkstra to leave | Alliance |
03.07.2024 08:51 | VAL | Proposed Director Appointment | RNS |
20.06.2024 17:56 | VAL | Result of AGM | RNS |
19.06.2024 11:33 | VAL | Directorate Change | RNS |
17.06.2024 14:29 | VAL | IN BRIEF: ValiRx shares up as subsidiary inks contract with US firm | Alliance |
17.06.2024 07:00 | VAL | Inaphaea Contract Award | RNS |
28.05.2024 07:00 | VAL | Investor Webinar | RNS |
20.05.2024 14:21 | VAL | ValiRx shares jump as Cytolytix gets Knowledge Transfer Voucher grant | Alliance |
20.05.2024 12:00 | VAL | Business Update | RNS |
16.05.2024 16:29 | UPL, IDHC, TLW | EARNINGS AND TRADING: Tullow Oil on track to hit free cash flow target | Alliance |
16.05.2024 07:00 | VAL | Further re Final Results | RNS |
15.05.2024 18:38 | VTU, VAL, TGP | TRADING UPDATES: Vertu Motors ups dividend as hails record revenue | Alliance |
15.05.2024 10:45 | VAL, ORCP, ITIM | AIM WINNERS & LOSERS: Itim up on Majestic Wine contract renewal | Alliance |
15.05.2024 07:00 | VAL | Final Results and Notice of AGM | RNS |
22.04.2024 07:00 | VAL | Directorate Changes | RNS |
21.03.2024 11:22 | VAL | ValiRx inks evaluation deal with Imperial College London for research | Alliance |
21.03.2024 07:00 | VAL | Evaluation Agreement with Imperial College London | RNS |
19.03.2024 19:47 | API, CREI, ALL | EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat | Alliance |
19.03.2024 07:00 | VAL | Board Re-structuring and update on requisition | RNS |
04.03.2024 17:47 | VAL | Shareholder Requisition Notice | RNS |
04.03.2024 07:00 | VAL | Proposed Appointment of Non-Executive Director | RNS |
29.02.2024 14:00 | VAL | Proposed Appointment of Non-Executive Director | RNS |
13.02.2024 14:45 | VAL | ValiRx says requisition notice from shareholder group is invalid | Alliance |
13.02.2024 14:20 | VAL | Further re Shareholder Requisition Notice | RNS |
12.02.2024 17:33 | VAL | Holding(s) in Company | RNS |
12.02.2024 11:42 | VAL | IN BRIEF: ValiRx signs research sharing deal with Dundee University | Alliance |
12.02.2024 07:00 | VAL | Agreement with Dundee Uni and Project Initiation | RNS |
09.02.2024 20:24 | TPFG, VAL | TRADING UPDATES: ValiRx receives shareholder request for board change | Alliance |
09.02.2024 17:06 | VAL | Shareholder Requisition Notice | RNS |
19.01.2024 07:00 | VAL | Change of Broker | RNS |
18.01.2024 07:00 | VAL | Directorate Change | RNS |
04.01.2024 13:48 | VAL | Result of GM, Issue of Equity | RNS |
28.12.2023 15:56 | VAL | UK shareholder meetings calendar - next 7 days | Alliance |
19.12.2023 20:46 | VAL | IN BRIEF: ValiRx raises GBP192,200, part of wider GBP1.8 million raise | Alliance |
19.12.2023 18:11 | VAL | Result of Retail Offer, Subscription | RNS |
15.12.2023 07:00 | VAL | Posting of Circular, Notice of GM and Ops Review | RNS |
13.12.2023 21:14 | ASIA, MACF, CREO | TRADING UPDATES: Good Energy says ZapMap expands into mainland Europe | Alliance |
13.12.2023 16:56 | VAL | Retail Offer | RNS |
13.12.2023 16:49 | VAL | Conditional Fundraise, Notice of General Meeting | RNS |
05.12.2023 11:17 | VAL | ValiRx says ValiSeek inks deal to licence VAL401 drug with Ambrose | Alliance |